Crossmark

Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil

Crossref DOI link: https://doi.org/10.1016/j.bjid.2023.102745

Published Print: 2023-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dufrayer, Mauro Cesar http://orcid.org/0000-0002-1324-9687
Rechenmacher, Ciliana http://orcid.org/0000-0002-1321-5807
Meneses, Clarice Franco http://orcid.org/0000-0002-9321-2066
Monteiro, Yasmine Massaro Carneiro http://orcid.org/0000-0002-8634-276X
Carlesse, Fabianne Altruda de Moraes Costa http://orcid.org/0000-0001-7037-3425
Motta, Fabrizio http://orcid.org/0000-0001-9375-6517
Daudt, Liane Esteves http://orcid.org/0000-0001-9495-6932
Michalowski, Mariana Bohns http://orcid.org/0000-0002-9482-0776
License Information

Text and Data Mining valid from 2023-03-01

Version of Record valid from 2023-01-28
More Information

This article is maintained by: Elsevier

Article Title: Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2023.102745

Content Type: article

Copyright: © 2023 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below